SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

BMO Capital Maintains Market Perform on Amphastar Pharmaceuticals, Raises Price Target to $21

BMO Capital maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Market Perform and raises the price target from $20 to $21.

Benzinga · 05/11/2020 16:07

BMO Capital maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Market Perform and raises the price target from $20 to $21.